BEYONDSPRING INC (BYSI)
KYG108301006 - Common Stock
BEYONDSPRING INC
NASDAQ:BYSI (4/22/2024, 3:30:01 PM)
2.11
+0.2 (+10.47%)
Company Profile
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in Florham Park, New Jersey and currently employs 67 full-time employees. The company went IPO on 2017-03-09. The firm is focused on using its technology platform for drug discovery and the development of therapies to improve clinical outcomes for patients with high unmet medical needs. The firm operates through two segments: the Plinabulin pipeline and Targeted Protein Degradation (TPD) platform. Plinabulin is being developed as a pipeline in a drug in various cancer indications as a direct anti-cancer agent and to prevent chemotherapy-induced neutropenia (CIN). Plinabulin is a small molecule derived from a natural compound found in marine microorganisms. The company is a selective immunomodulating microtubule-binding agent (SIMBA), which may provide multiple therapeutic opportunities. The TPD platform is utilizing molecular glue technology to develop therapeutic agents and discover and develop new chemical entities for debilitating diseases and disorders. The firm is also developing three small-molecule immune agents.
Company Info
BEYONDSPRING INC
100 Campus Drive, West Side, 4Th Floor, Suite 410
Florham Park NEW JERSEY 10005
P: 16465284184
CEO: Lan Huang
Employees: 67
BYSI News
FLORHAM PARK, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global...
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
2 months ago - Seeking AlphaBeyondSpring regains Nasdaq compliance as price surges above $1 (NASDAQ:BYSI)BeyondSpring regains compliance with Nasdaq minimum bid price requirement, with the stock trading at $1.09 on Monday.
3 months ago - Seeking AlphaBeyondSpring gets Nasdaq delinquency notice (NASDAQ:BYSI)BeyondSpring (BYSI) is facing non-compliance with Nasdaq as it failed to file its Form 6-K.
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical...
4 months ago - Seeking AlphaBeyondSpring receives Nasdaq notice regarding minimum bid price requirements (NASDAQ:BYSI)BeyondSpring (BYSI) received a notification from Nasdaq regarding its non-compliance with the minimum closing bid price requirement; no immediate delisting.
BYSI Twits
Here you can normally see the latest stock twits on BYSI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
